• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Nanomol Technologies present at Clinam 2018 Summit
18 September 2018

Nanomol Technologies present at Clinam 2018 Summit

The CLINAM Summit is a globally unique event that brings together all stakeholders in nanomedicine, targeted medicine and precision medicine. Our CEO Santi Sala has participated into the session Presentations on Nanoparticles – Analytics, Methods and Technologies by presenting the work Technology platform for the production of lipid-based nanovesicles as new nanomedicines. By this presentation he has described latest developments related to our projects Nano-Nafres which belongs to the RIS3CAT community “Technologies applied to health”, and Horizon 2020 project “Smart-4-Fabry” – Smart multifunctional GLA-nanoformulation for Fabry disease. He has presented as well our cGMP contract analysis services on micro and nanoparticles characterization techniques.

Related
news

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug 28 February 2021

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

NANOMOL TECHNOLOGIES GETS DEEPER IN THE DEVELOPMENT OF ARTIFICIAL INTELLIGENCE TOOLS FOR THE IMAGE ANALYSIS FROM ELECTRONIC MICROSCOPE IMAGES. 23 November 2023

NANOMOL TECHNOLOGIES GETS DEEPER IN THE DEVELOPMENT OF ARTIFICIAL INTELLIGENCE TOOLS FOR THE IMAGE ANALYSIS FROM ELECTRONIC MICROSCOPE IMAGES.

WORKSHOP IN HONOUR OF OUR COFOUNDERS PROFS JAUME VECIANA & CONCEPCIÓ ROVIRA 01 October 2021

WORKSHOP IN HONOUR OF OUR COFOUNDERS PROFS JAUME VECIANA & CONCEPCIÓ ROVIRA

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki